How did GCAN's recent EPS compare to expectations?
The most recent EPS for Greater Cannabis Company Inc is $, expectations of $.
How did Greater Cannabis Company Inc GCAN's revenue perform in the last quarter?
Greater Cannabis Company Inc revenue for the last quarter is $
What is the revenue estimate for Greater Cannabis Company Inc?
According to of Wall street analyst, the revenue estimate of Greater Cannabis Company Inc range from $ to $
What's the earning quality score for Greater Cannabis Company Inc?
Greater Cannabis Company Inc has a earning quality score of B+/48.819225. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Greater Cannabis Company Inc report earnings?
Greater Cannabis Company Inc next earnings report is expected in
What are Greater Cannabis Company Inc's expected earnings?
Greater Cannabis Company Inc expected earnings is $, according to wall-street analysts.
Did Greater Cannabis Company Inc beat earnings expectations?
Greater Cannabis Company Inc recent earnings of $ expectations.
Key Stats
Prev.Close
$0.28
Open
$0.3777
Day's Range
$0.3777 - $0.3777
52 week range
$0.0003 - $0.3777
Volume
110
Avg.Volume
99.1M
Dividend yield
--
EPS (TTM)
-745.54
Market Cap
$355.0K
What is GCAN?
The Greater Cannabis Co., Inc. engages in the business of cannabis related investment and development opportunities through online retail store, direct equity investments, joint ventures, licensing agreements, or acquisitions. The company is headquartered in Baltimore, Maryland and currently employs 1 full-time employees. The company went IPO on 2018-07-09. The firm is involved in additional research and development of cannabinoid-based therapeutics that reduce disruptive symptoms in patients suffering from neuropsychiatric disorders. The firm also focuses on developing new formulations around cannabinoid therapeutics. Its wholly owned subsidiary is Biocanrx, Inc.